Photodissociation of S atom containing amino acid chromophores.

The Journal of chemical physics (2007-08-21)
Ming-Fu Lin, Yuri A Dyakov, Yuan T Lee, S H Lin, Alexander M Mebel, Chi-Kung Ni
ABSTRACT

Photodissociation of 3-(methylthio)propylamine and cysteamine, the chromophores of S atom containing amino acid methionine and cysteine, respectively, was studied separately in a molecular beam at 193 nm using multimass ion imaging techniques. Four dissociation channels were observed for 3-(methylthio)propylamine, including (1) CH(3)SCH(2)CH(2)CH(2)NH(2)-->CH(3)SCH(2)CH(2)CH(2)NH+H, (2) CH(3)SCH(2)CH(2)CH(2)NH(2)-->CH(3)+SCH(2)CH(2)CH(2)NH(2), (3) CH(3)SCH(2)CH(2)CH(2)NH(2)-->CH(3)S+CH(2)CH(2)CH(2)NH(2), and (4) CH(3)SCH(2)CH(2)CH(2)NH(2)-->CH(3)SCH(2)+CH(2)CH(2)NH(2). Two dissociation channels were observed from cysteamine, including (5) HSCH(2)CH(2)NH(2)-->HS+CH(2)CH(2)NH(2) and (6) HSCH(2)CH(2)NH(2)-->HSCH(2)+CH(2)NH(2). The photofragment translational energy distributions suggest that reaction (1) and parts of the reactions (2), (3), (5) occur on the repulsive excited states. However, reaction (4), (6) occur only after the internal conversion to the electronic ground state. Since the dissociation from an excited state with a repulsive potential energy surface is very fast, it would not be quenched completely even in the condensed phase. Our results indicate that reactions following dissociation may play an important role in the UV photochemistry of S atom containing amino acid chromophores in the condensed phase. A comparison with the potential energy surface from ab initio calculations and branching ratios from RRKM calculations was made.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
3-(Methylthio)propylamine, 97%

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.